Poland· PL-100454503
Evrenzo
A roxadustat product containing roxadustatum, registered in Poland by Astellas Pharma Europe B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Roxadustat is registered in 13 of 19 countries.
Countries holding a registration under ATC B03XA05 (roxadustat), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Roxadustat · ATC B03XA05
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
Price per daily dose
What a daily dose of roxadustat costs, country by country.
Normalised to the WHO defined daily dose (43 mg), the median price runs from $23.73 in Italy to $77.81 in France — a ×3.3 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Roxadustat · price per daily dose (43 mg)
USD · FX 28 Sept 2026
- FR France$77.81
- IT Italy$23.73
The record
At a glance
URPL (Poland)- Active substance
- Roxadustatum
- Manufacturer
- Astellas Pharma Europe B.V.
- Country
- Poland (PL)
- ATC code
- B03XA05
- ATC class
- Roxadustat
- Defined daily dose
- 43 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991458706
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Roxadustat in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaEVRENZOAstellas Pharma Europe B.V., Leiden
- FinlandEvrenzoAstellas Pharma Europe B.V.
- FranceEVRENZO 50 mg, comprimé pelliculéASTELLAS PHARMA EUROPE (PAYS-BAS)
- IrelandEvrenzo 50 mg Film-coated tabletAstellas Pharma Europe B.V.
- IcelandEvrenzoAstellas Pharma Europe B.V.
- NetherlandsEvrenzo 50 mg filmomhulde tablettenAstellas Pharma Europe B.V.
- NorwayEvrenzoAstellas Pharma Europe B.V. - Leiden
- BelgiumEvrenzo 50 mgAstellas Pharma Europe
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Evrenzo
- Liechtenstein · Evrenzo
- Norway · Evrenzo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/82bf28b5-7bbc-44ac-8817-6dc0e07d9e1d GET /v1/drugs/82bf28b5-7bbc-44ac-8817-6dc0e07d9e1d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "50 mg",
"packaging": "05909991458706 ¦ Rp ¦ EU/1/21/1574/002 ¦ 140932\n12 tabl.\nRp ¦ EU/1/21/1574/007 ¦ 159379\n36 tabl. w blistrze perforowanym",
"substance": "Roxadustatum 50 mg",
"common_name": "Roxadustatum",
"pl_product_id": "100454503",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about roxadustat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.